Abstract: A method of cancer hyperthermia therapy includes placing a device including an exogenously-excitable polymeric material at a cancer hyperthermia therapy site of a patient. The method also includes supplying an exogenous energy to the device such that the exogenous energy excites the exogenously-excitable polymeric material at the cancer hyperthermia therapy site to heat the cancer hyperthermia therapy site to a hyperthermia temperature. A method of preparing a polymeric material includes combining an alcohol monomer, a seed of the polymeric material, and an aqueous liquid in a vessel. The method also includes adding an acid monomer to the vessel and supplying an exogenous energy to the vessel. The polymeric material is exogenously excited by the exogenous energy to heat the polymeric material. The method further includes removing water from the vessel and producing the polymeric material, which is a polyester, in the vessel.

Abstract: A water-mediated process prepares a polymeric (meth)acrylation composition. In some embodiments, the process includes providing a stabilized aqueous solution including a (meth)acrylation component and a polyol monomer in a vessel under an inert atmosphere and adding a diacid monomer to the vessel under the inert atmosphere. In some embodiments, the process includes providing a stabilized aqueous solution including a (meth)acrylation component and a copolymer of a polyol monomer and a diacid monomer in a vessel under an inert atmosphere. The process further includes heating and removing water from the vessel under the inert atmosphere to produce the polymeric (meth)acrylation composition. The polymeric (meth)acrylation composition includes a (meth)acrylation polyester copolymer of the diacid monomer and the polyol monomer with the (meth)acrylation component conjugated to the (meth)acrylation polyester copolymer.

Abstract: In some embodiments, a polymer film includes a base composition of poly(ethylene-vinyl acetate) and a surface composition comprising hydroxy groups. In some embodiments, a polymer film includes a base layer of a first composition of poly(ethylene-vinyl acetate), a surface layer at a surface of the base layer, and a coating layer of a second composition of a copolymer of glycerol and sebacic acid. The surface layer includes surface hydroxy groups converted from acetate groups of the poly(ethylene-vinyl acetate). The second composition is attached to the surface layer by ester bonds between carboxyl groups of the copolymer and the hydroxy groups. A single-use bioreactor bag includes a polymer film including a base composition of poly(ethylene-vinyl acetate) and a surface composition comprising hydroxy groups. A method of modifying a poly(ethylene-vinyl acetate) film includes converting acetate groups at a first surface of the poly(ethylene-vinyl acetate) film to hydroxy groups.

Abstract: A system for apportioning reductant dosing amounts in multi-doser architectures includes an engine, an aftertreatment system in fluid communication with the engine, and a controller. The aftertreatment system includes a first doser configured to dose reductant into a first decomposition reaction member and a second doser configured to dose reductant into a second decomposition reaction member. The controller receives engine operating conditions and determines a total reductant amount based on the engine operating conditions. The controller also apportions the total reductant amount into a first apportioned reductant amount based on a first maximum reductant dosing amount for the first doser and a second apportioned reductant amount based on a second maximum reductant dosing amount for the second doser. The controller outputs a first apportioned reductant dosing command to the first doser and a second apportioned reductant dosing command to the second doser.

Abstract: An exhaust elbow includes an upstream sidewall defining an upstream portion of the exhaust elbow, a downstream sidewall defining a downstream portion of the exhaust elbow, and a deflector. The upstream portion is configured to receive an upstream exhaust gas. The deflector is coupled to the upstream sidewall of the exhaust elbow upstream and is configured to deflect a portion of the upstream exhaust gas received by the upstream portion of the exhaust elbow away from a region of an interior of the exhaust elbow into which an injected reductant from a dosing module is injected. The deflector may reduce and/or prevent formation of reductant deposits on a downstream sidewall. In some implementations, an exhaust assisted flow separator may also be included to direct a portion of the upstream exhaust gas received by the upstream portion of the exhaust elbow through a dosing opening.

Abstract: A system for apportioning reductant dosing amounts in multi-doser architectures includes an engine, an aftertreatment system in fluid communication with the engine, and a controller. The aftertreatment system includes a first doser configured to dose reductant into a first decomposition reaction member and a second doser configured to dose reductant into a second decomposition reaction member. The controller receives engine operating conditions and determines a total reductant amount based on the engine operating conditions. The controller also apportions the total reductant amount into a first apportioned reductant amount based on a first maximum reductant dosing amount for the first doser and a second apportioned reductant amount based on a second maximum reductant dosing amount for the second doser. The controller outputs a first apportioned reductant dosing command to the first doser and a second apportioned reductant dosing command to the second doser.

Abstract: An exhaust elbow includes an upstream sidewall defining an upstream portion of the exhaust elbow, a downstream sidewall defining a downstream portion of the exhaust elbow, and a deflector. The upstream portion is configured to receive an upstream exhaust gas. The deflector is coupled to the upstream sidewall of the exhaust elbow upstream and is configured to deflect a portion of the upstream exhaust gas received by the upstream portion of the exhaust elbow away from a region of an interior of the exhaust elbow into which an injected reductant from a dosing module is injected. The deflector may reduce and/or prevent formation of reductant deposits on a downstream sidewall. In some implementations, an exhaust assisted flow separator may also be included to direct a portion of the upstream exhaust gas received by the upstream portion of the exhaust elbow through a dosing opening.